(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) said yesterday it has awarded contracts to two companies to develop vaccines based on the H5N1 avian influenza virus in an effort to limit the risk of a human influenza pandemic.
(CIDRAP News) An influenza virusespecially one genetically manipulated for increased virulencewould be an attractive weapon for bioterrorists, according to physicians writing in the Journal of the Royal Society of Medicine.
